
Tenet Healthcare (THC) Stock Forecast & Price Target
Tenet Healthcare (THC) Analyst Ratings
Bulls say
Tenet Healthcare is well-positioned in the healthcare industry as one of the largest acute-care hospital operators in the US with 50 hospitals and over 380 ambulatory surgery centers. The company's 1Q26 results showed solid revenue growth despite winter weather challenges, with growth expected to continue as management raised their adjusted EPS outlook for the year. Risks to the positive outlook include potential headwinds from the loss of HIX eAPTCs and declining high-acuity volumes, but the company's strong operational discipline and continued growth in the USPI segment make it an attractive long-term investment opportunity.
Bears say
Tenet Healthcare is facing numerous challenges in the current healthcare landscape, including potential changes in healthcare policies and regulations, reduced government funding, and challenges with its hospital and ambulatory surgery center operations. These challenges could significantly impact the company's revenue and profitability, leading to a negative outlook for its stock. In addition, the company's high levels of debt and low free cash flow generation add further concerns about its financial stability. Its recent underperformance compared to its past 5-year average and a lower projected valuation also contribute to the negative outlook.
This aggregate rating is based on analysts' research of Tenet Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Tenet Healthcare (THC) Analyst Forecast & Price Prediction
Start investing in Tenet Healthcare (THC)
Order type
Buy in
Order amount
Est. shares
0 shares